Company: ELV
Filing Date: 2025-07-17
Form Type: 10-Q
Source: 0001156039-25-000114
Chunk: 95

Company: Elevance Health, Inc.
Filing Date: 2025-07-17
Form: 10-Q
Item: Item 2
Chunk 95
---
 revenue to the amounts of total revenue included in the consolidated statements of income and a reconciliation of income before income tax expense to reportable segments’ operating gain, see Note 15, “Segment Information,” of the Notes to Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.

We report our results of operations in the following four reportable segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other (our businesses that do not individually meet the quantitative thresholds for an operating segment, as well as corporate expenses not allocated to our other reportable segments). For additional information, see Note 15, “Segment Information,” of the Notes to Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q. 

-47-

The following table presents a summary of the reportable segment financial information for the three and six months ended June 30, 2025 and 2024:

 Six Months Ended  June 30Three Months Ended  June 30Three Months Ended June 30Six Months Ended June 30 2025 vs. 2024 Change2025 vs. 20242025202420252024$%$%Operating RevenueHealth Benefits$41,582$37,159$83,013$74,417$4,423 11.9 %$8,596 11.6 %CarelonRx10,6438,77420,75916,8411,869 21.3 %3,918 23.3 %Carelon Services7,4414,54513,9778,5542,896 63.7 %5,423 63.4 %Corporate & Other232122397249110 90.2 %148 59.4 %Eliminations (10,477)(7,377)(19,960)(14,565)(3,100)42.0 %(5,395)37.0 %Total operating revenue$49,421$43,223$98,186$85,496$6,198 14.3 %$12,690 14.8 %Operating Gain (Loss)Health Benefits$1,560$2,145$3,777$4,432$(585)(27.3)%$(655)(14.8)%CarelonRx5364971,1381,02039 7.8